MarketBeat
06 Nov 2026, 08:15 UTC · 1h ago
IBEX Q1 Earnings Call Highlights
Impact · against what's priced in
IBEX is seeing strong operational momentum with record Q1 revenue and an upward revision to its fiscal 2027 guidance. The combination of AI-driven client wins and significant margin expansion suggests an earnings beat is likely, as the company leverages its HealthTech vertical and AI partnerships to drive growth.
- IBEX+0.70
No priced-in read yet
- In context
The company raised its fiscal 2027 revenue guidance to $720M-$735M and adjusted EBITDA to $96M-$99M, supported by a 29% jump in Q1 adjusted EBITDA and seven new AI/outsourcing contracts expected to launch this quarter.
Read from the article alone





